openPR Logo
Press release

Dyspepsia Market is likely to register double digit CAGR during 2017 to 2025

11-03-2017 08:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

Dyspepsia Market is likely to register double digit CAGR during

Dyspepsia is a clinical condition in which the digestive capacity of the body is impaired causing various symptoms such as bloating, belching, nausea, and burning sensation in the chest. The two types of dyspepsia are: functional and undifferentiated. Functional dyspepsia occurs without any strong evidence of disease and is likely to affect approximately 15% of the general population in the U.S. and Europe. Undifferentiated dyspepsia can be caused due to peptic ulcer disease of stomach or duodenum. It may also be caused due to gastritis and gastro esophageal reflux disorder (GERD). The symptoms of dyspepsia are more common after 55 years of age.

Get PDF Brochure for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31496

The global dyspepsia market can be segmented based on type, end-user, and region. In terms of type, the market can be categorized into organic and functional. Organic causes of dyspepsia are esophageal cancer, pancreatic disorders, peptic ulcers, other infectious diseases, intolerance to drugs and foods, etc.

Indefinite organic cause can be determined in around 70% of the patients suffering from dyspepsia and this condition is termed as non-ulcer or functional dyspepsia. Diagnosis of this condition can be confirmed with the presence of epigastralgia for a period of more than six months. Majority of the patients who have dyspepsia suffer from functional dyspepsia and these patients have normal gut lining without any inflammation. This condition is common and can appear for no apparent reason. Some of the theories that have been proposed to be the most probable causes of this condition are delayed emptying of the stomach (stomach disorder) contents into duodenum, high acid sensitivity of the tissues lining duodenum and stomach, and infection with Helicobacter pylori bacterium can result in this condition as this bacterium can be detected in patients with non-ulcer dyspepsia

This disease may worsen and lead to severe symptoms such as upper abdominal pain, bloating sensation, unintentional weight loss, fullness, and occasionally palpitations. It may sometimes mask the symptoms of angina pain. Other conditions such as gastric malignancy, medication related ulceration, and other causes are ruled out prior to the treatment of dyspepsia.

The treatment options for dyspepsia include changes in dietary habits such as eating bland food, avoidance of spicy and oily food is advised by physicians. Food products such as chocolates, mint, and alcohol may worsen dyspepsia.

Medical drugs effective in the treatment of this disease include antacids such as Alka-Seltzer, Rolaids, Riopan, Maalox, and Mylanta. These are over-the-counter medicines and do not require prescriptions. Other drugs apart from antacids are H-2 receptors such as Tagament, Zantac, Axid, and Pepcid. Proton pump inhibitors are also administered for treatment of GERD and comprises brand drugs such as Nexium, Cipher, Prevacid, Protonix, Prilosec, and Zegerid. In cases of no identifiable cause, antidepressants have helped in reducing dyspeptic conditions such as nausea, headache, constipation, and night sweats.

In terms of end-user, the global dyspepsia market can be segmented into hospitals, diagnostic centers, academic and research institutes, and others. Geographically, the global dyspepsia market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market, due to technological advancements, favorable reimbursement, and acceptance of minimally invasive techniques by the population.

Request for Report ToC: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=31496

Major pharmaceutical players such as Pfizer, GSK, Novartis, Thermo Fisher Scientific, Sanofi, Merck, and other generic players have strong presence in this market.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
90 State Street,
Suite 700
Albany NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
E-mail: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dyspepsia Market is likely to register double digit CAGR during 2017 to 2025 here

News-ID: 799899 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Dyspepsia

Functional Dyspepsia Market to Show a Rise During the Forecast Period, asserts D …
DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as the Functional Dyspepsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Functional Dyspepsia market report provides current treatment practices, emerging drugs, Functional Dyspepsia market share of the individual therapies, and current and forecasted Functional Dyspepsia market
Functional Dyspepsia Drug Market Size 2021 By Trends Evaluation Forecast to 2027
The Global Functional Dyspepsia Drug Market Report 2021 to 2027 could be a fundamental examination of the global analysis. Trending innovation, advertise drivers, sectional declination, analysis measurements, advertise forecasts, manufacturers, and hardware merchants are all included within the substance. The report incorporates a point-by-point examination of the Functional Dyspepsia Drug Market as well as empowering advances, current patterns, openings, and obstruction, as well as a self-governing point of view, arrangement
Functional Dyspepsia Therapeutics- Pipeline Analysis 2018
Functional dyspepsia, also known as non-ulcer dyspepsia, is a gastrointestinal disorder that causes peristalsis and sensations in the upper digestive tract. Inflammation of the stomach or duodenum, excessive acid secretion, psychological factors, lifestyle and diet influences, food allergies, Helicobacter pylori infection, and side effects of medications are some causes of functional dyspepsia. Download the sample report at: https://www.pharmaproff.com/request-sample/1027 The risk factors associated with this disease are smoking, consumption of alcohol, consumption of
Dyspepsia Market Key Manufacturers, Development Trends And Competitive Analysis …
Dyspepsia is a clinical condition in which the digestive capacity of the body is impaired causing various symptoms such as bloating, belching, nausea, and burning sensation in the chest. The two types of dyspepsia are: functional and undifferentiated. Functional dyspepsia occurs without any strong evidence of disease and is likely to affect approximately 15% of the general population in the U.S. and Europe. Undifferentiated dyspepsia can be caused due to
Dyspepsia Market Size will Grow at a Robust Pace through 2017 – 2025
Dyspepsia is a clinical condition in which the digestive capacity of the body is impaired causing various symptoms such as bloating, belching, nausea, and burning sensation in the chest. The two types of dyspepsia are: functional and undifferentiated. Functional dyspepsia occurs without any strong evidence of disease and is likely to affect approximately 15% of the general population in the U.S. and Europe. Undifferentiated dyspepsia can be caused due to
Functional (Non Ulcer) Dyspepsia - Pipeline Review and Market Trend H2 2017
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1230588 Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause.